Mike has an outstanding track record in the pharmaceutical industry, and brings fantastic energy and leadership skills to the position.
Hercules, CA (PRWEB) April 13, 2015
Pacific BioLabs, a GLP/GMP pharmaceutical and medical device contract research organization, today announced the appointment of Michael Yakes, PhD as Vice President of Toxicology, responsible for all toxicology, PK/ADME, bioassay, and biocompatibility testing.
Dr. Yakes has spent 14 years in the pharmaceutical industry, directing pharmacology programs and managing a team of 44 researchers for Exelixis, and was the Senior Director of Translational Biology for Cleave Biosciences, overseeing toxicology, DMPK, and pharmacology studies.
“We are extremely pleased to welcome Mike to PBL,” said Tom Spalding, President of Pacific BioLabs. “Mike has an outstanding track record in the pharmaceutical industry, and brings fantastic energy and leadership skills to the position. I’m confident that our current clients will enjoy working with Mike, and that his entrepreneurial skills and business acumen will help PBL continue to grow.”
About Pacific BioLabs
Pacific BioLabs is a contract research organization providing a broad array of development and manufacturing support services to the pharmaceutical, biotech, and medical device industries. By supporting these industries through GLP and GMP testing services, Pacific BioLabs helps to bring life-saving and life-improving therapies and devices to patients who need them. Located in Hercules, CA, Pacific BioLabs operates out of a state-of-the-art, purpose-built 32,000 square foot facility overlooking the San Francisco Bay. For more information, please visit http://www.pacificbiolabs.com.